Surgery Partners annual meeting re-elects Class II directors, approves say-on-pay, ratifies auditor

Proposal 2: Advisory vote on executive compensation. The stockholders approved on a non-binding, advisory basis the compensation paid by the Company to its named executive officers, as disclosed in the Company's Definitive Proxy Statement on Schedule 14A, filed with the Securities and Exchange Commission on April 20, 2023. The results of the vote were as follows: Votes For Votes Against Abstentions Broker Non-Votes 118,127,561 3,307,178 7,989 1,463,498

Proposal 3: Advisory vote on frequency of future executive compensation votes. The stockholders approved on a non-binding, advisory basis that a non-binding, advisory stockholder vote on the compensation paid to the Company's named executive officers shall occur annually. The results of the vote were as follows: One Year Two Years Three Years Abstentions Broker Non-Votes 120,851,075 6,631 575,732 9,290 1,463,498

Proposal 4: Ratification of the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for fiscal year 2023. The stockholders ratified the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023. The results of the vote were as follows: Votes For Votes Against Abstentions 122,861,637 40,051 4,538

Proposal 1: Election of Class II directors. The stockholders elected each of the director nominees to serve as a Class II director until the Company’s 2026 annual meeting of stockholders and until each such successor has been elected and qualified. Each of the nominees was a current Class II director of the Company who was re-elected. The results of the vote were as follows: Name Votes For Votes Withheld Broker Non-Votes Patricia A. Maryland, Dr.PH 107,534,448 13,894,991 1,476,787 T. Devin O'Reilly 105,594,699 15,834,740 1,476,787 Brent Turner 114,973,075 6,469,653 1,463,498